Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug

By: via Benzinga
Bristol-Myers Squibb Co. (NYSE: BMY) gained slightly Friday on news it brought a patent suit against Merck & Co., Inc. (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.